About.
Luigi Catanzariti, PhD
Founder and Principal
Luigi Catanzariti, Ph.D., is the founder and principal of Catanzariti & Associates, a Boston area-based private group specializing in strategic consulting, and business development services in the emerging field of precision medicine. From 2009-2016 he led Rx/CDx co-development projects for Novartis oncology in Cambridge, Massachusetts. His responsibility included leading cross-functional teams (consisting of regulatory, technical, clinical, and business development representatives) and the creation of precision medicine strategies from clinical trial patient selection to Rx/CDx co-approvals. He is the author/co-author of international diagnostic and biomarker patents.
Since 2017, Dr. Catanzariti has been an independent consultant to numerous biotechs/pharma groups and helped them align their Rx/CDx precision medicine programs to ensure optimal execution.
